398 related articles for article (PubMed ID: 18067129)
1. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
[TBL] [Abstract][Full Text] [Related]
2. Effect of regular 3-yearly screening on the incidence of cervical smears: the Leiden experience.
Boon ME; de Graaff Guilloud JC; Rietveld WJ; Wijsman-Grootendorst A
Cytopathology; 1990; 1(4):201-10. PubMed ID: 2101670
[TBL] [Abstract][Full Text] [Related]
3. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
Nieminen P; Kallio M; Hakama M
Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
[TBL] [Abstract][Full Text] [Related]
4. Urbanization and the incidence of abnormalities of squamous and glandular epithelium of the cervix.
Boon ME; van Ravenswaay Claasen HH; van Westering RP; Kok LP
Cancer; 2003 Feb; 99(1):4-8. PubMed ID: 12589639
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
6. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
7. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
8. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
9. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
[TBL] [Abstract][Full Text] [Related]
10. Population screening for cervical cancer in the region of Nijmegen, The Netherlands 1976-1985.
van der Graaf Y; Vooijs PG; Zielhuis GA
Gynecol Oncol; 1988 Jul; 30(3):388-97. PubMed ID: 3391422
[TBL] [Abstract][Full Text] [Related]
11. [Results of the Leiden mass screening for cervix uteri carcinoma; the 'young' (24-34 years) versus the 'old' (35-54 years) group of women].
Boon ME; de Graaff Guilloud-Gentenaar JC; Beck S
Ned Tijdschr Geneeskd; 1990 Aug; 134(32):1545-9. PubMed ID: 2392176
[TBL] [Abstract][Full Text] [Related]
12. Reasons for cervical cancer despite extensive screening.
Stenkvist B; Söderström J
J Med Screen; 1996; 3(4):204-7. PubMed ID: 9041486
[TBL] [Abstract][Full Text] [Related]
13. A screening programme for cervical cancer that worked.
Hakama M; Louhivuori K
Cancer Surv; 1988; 7(3):403-16. PubMed ID: 3242792
[TBL] [Abstract][Full Text] [Related]
14. [Cervical cancer after 10 years of nationally coordinated screening].
Haldorsen T; Skare GB; Steen R; Thoresen SO
Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women.
Bulk S; Visser O; Rozendaal L; Verheijen RH; Meijer CJ
Int J Cancer; 2005 Mar; 113(6):1005-9. PubMed ID: 15515017
[TBL] [Abstract][Full Text] [Related]
16. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
17. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.
Anttila A; Pukkala E; Söderman B; Kallio M; Nieminen P; Hakama M
Int J Cancer; 1999 Sep; 83(1):59-65. PubMed ID: 10449609
[TBL] [Abstract][Full Text] [Related]
18. 1991 cervical screening recommendations: a working group report.
Paul C; Bagshaw S; Bonita R; Durham G; Fitzgerald NW; Jones RW; Marshall B; McAvoy BR
N Z Med J; 1991 Jul; 104(915):291-5. PubMed ID: 1906587
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening. Past success and future challenge.
Dewar MA; Hall K; Perchalski J
Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
[TBL] [Abstract][Full Text] [Related]
20. Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications.
Hakama M; Joutsenlahti U; Virtanen A; Räsänen-Virtanen U
Ann Clin Res; 1975 Apr; 7(2):101-11. PubMed ID: 1181974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]